This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Researchers in Belgium and the Netherlands conducted a diagnostic accuracy study to determine if the use of fecal calprotectin as a screening test for inflammatory bowel disease (IBD) could reduce the number of children undergoing endoscopy. Participants included children and teens 6 to 18 years of age with abdominal complaints suggesting IBD who were evaluated in pediatric clinics of 6 general hospitals and 1 tertiary care hospital in northern Holland. Inclusion criteria included persistent diarrhea for >4 weeks or recurrent (>2 episodes in 6 months) abdominal pain and diarrhea, and at least 1 of the following: rectal bleeding, unintended weight loss, linear growth retardation, perianal symptoms (skin tag, fistula, fissure, or abscess), anemia, other extraintestinal manifestations (erythema nodosum, arthritis, uveitis), or increased inflammatory markers (ESR or CRP). At entry, a stool sample was …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Purchase access
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.